Multimodal Brain Radiomics for Predicting Pathological Subtypes of Lung Cancer Brain Metastases: Impact of Imaging Modality, MRI Sequence, and Spatial Extent.

RATIONALE AND OBJECTIVES: To develop and validate a brain imaging-based multimodal radiomics model for noninvasive prediction of pathological subtypes in lung cancer patients with brain metastases, and to evaluate the effects of imaging modalities, computed tomography, contrast-enhanced T1-weighted imaging, T2-weighted imaging (CT, CE-T1WI, T2WI), and spatial ranges (tumor vs whole-brain) on model performance for optimizing diagnosis and treatment strategy. MATERIALS AND METHODS: A total of 255 lung cancer patients with pathologically confirmed brain metastases were retrospectively enrolled and divided into training and test cohorts at a 7:3 ratio. Radiomic features were extracted from tumor and whole-brain regions on CT, CE-T1WI, and T2WI after image preprocessing. Feature selection was performed via Z-score normalization, t-test, Pearson correlation, minimum redundancy maximum relevance, and least absolute shrinkage and selection operator. Single-modal, spatial-specific, and CT-magnetic resonance imaging (MRI) multimodal models were constructed using multiple machine learning algorithms. Model performance was validated by receiver operating characteristic-area under the curve (AUC), DeLong test, Brier score, calibration curve, decision curve analysis, integrated discrimination improvement, and net reclassification improvement, with SHapley Additive exPlanations adopted for model interpretation. RESULTS: The multimodal fusion model yielded the highest AUC of 0.883 in the test cohort with good calibration and clinical net benefit. The T1WI model outperformed the T2WI, and whole-brain-based models were significantly superior to tumor-region models. Spatial range exerted a greater impact on predictive performance than the imaging sequence. Accordingly, an imaging-clinical integrated model (AUC = 0.890) was established with the objective of further enhancing the model's comprehensive predictive performance and clinical applicability. CONCLUSION: The CT-MRI multimodal radiomics model accurately predicts pathological subtypes of lung cancer brain metastases. Spatial extent is a critical determinant for model performance.